Skip to main content

Advertisement

SpringerLink
Log in

Envisaging an alpha therapy programme in the atomic energy establishments: the priorities and the nuances

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Elgqvist J. Targeted alpha therapy: part I. Curr Radiopharm. 2011;4(3):176.

    Article  CAS  PubMed  Google Scholar 

  2. Oyen WJ, de Bono JS. Targeted α-based treatment of metastatic castration-resistant prostate cancer: revolutionizing systemic radiotherapy? J Nucl Med. 2016;57(12):1838–9.

    Article  PubMed  Google Scholar 

  3. Basu S, Banerjee S. Developing a dedicated comprehensive α-radionuclide therapy program: should this be the vision of the atomic energy programs in the next decade? Nucl Med Commun. 2017;38(2):103–5.

    Article  PubMed  Google Scholar 

  4. Ayed T, Pilmé J, Tézé D, Bassal F, Barbet J, Chérel M, et al. At-labeled agents for alpha-immunotherapy: on the in vivo stability of astatine-agent bonds. Eur J Med Chem. 2011;116:156–64.

    Article  Google Scholar 

  5. Wilbur DS. Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides. Curr Radiopharm. 2011;4(3):214–47.

    Article  CAS  PubMed  Google Scholar 

  6. Huang CY, Pourgholami MH, Allen BJ. Optimizing radioimmunoconjugate delivery in the treatment of solid tumor. Cancer Treat Rev. 2012;38(7):854–60.

    Article  CAS  PubMed  Google Scholar 

  7. Dekempeneer Y, Keyaerts M, Krasniqi A, Puttemans J, Muyldermans S, Lahoutte T, et al. Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle. Expert Opin Biol Ther. 2016;16(8):1035–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiation Medicine Centre (BARC), Tata Memorial Hospital Annexe Building, Jerbai Wadia Road, Parel, Mumbai, India, Pin Code 400 012

    Sandip Basu & Sharmila Banerjee

  2. Homi Bhabha National Institute, Mumbai, India

    Sandip Basu & Sharmila Banerjee

Authors
  1. Sandip Basu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharmila Banerjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sandip Basu.

Ethics declarations

Disclosure of potential conflicts of interest

No potential conflicts of interest

Research involving human participants and/or animals

Not applicable; Letter to the Editor

Informed consent

Not applicable; Letter to the Editor

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Basu, S., Banerjee, S. Envisaging an alpha therapy programme in the atomic energy establishments: the priorities and the nuances. Eur J Nucl Med Mol Imaging 44, 1244–1246 (2017). https://doi.org/10.1007/s00259-017-3686-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-017-3686-4

Keywords

Search

Navigation